Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03440307 · ClinicalTrials.gov registry record · NA
Intervention to Reduce Bisphenol A Exposure in Women
A NA study, sponsored by California Polytechnic State University-San Luis Obispo.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03440307: Completed NA study, sponsored by California Polytechnic State University-San Luis Obispo.
NCT03440307 is a NA study that has completed, run by California Polytechnic State University-San Luis Obispo. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03440307, a NA study, has completed, sponsored by California Polytechnic State University-San Luis Obispo.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a 3-week intervention reduces urinary Bisphenol A (BPA) in women with obesity
Primary Outcome
Change in urinary BPA measured at baseline and 3-weeks
Interventions
- BEHAVIORAL Face-to-Face Meetings
- BEHAVIORAL Email Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-11-12 |
| Est. Completion | 2017-11-11 |
| Phase | NA |
What the finished NCT03440307 record still lists
NCT03440307 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Face-to-Face Meetings is the first listed.
NCT03440307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03440307 about?
NCT03440307 is a clinical study titled "Intervention to Reduce Bisphenol A Exposure in Women". The purpose of this study is to determine whether a 3-week intervention reduces urinary Bisphenol A (BPA) in women with obesity
What is the current status of trial NCT03440307?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-11-12. Estimated completion is 2017-11-11.
What interventions are being tested in trial NCT03440307?
The interventions under investigation include: Face-to-Face Meetings (BEHAVIORAL), Email Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT03440307?
This trial is sponsored by California Polytechnic State University-San Luis Obispo, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03440307's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI